These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22294165)

  • 1. Practical aspects of radioligand binding.
    McKinney M; Raddatz R
    Curr Protoc Pharmacol; 2006 Jul; Chapter 1():Unit1.3. PubMed ID: 22294165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saturation analysis of ligand binding using a centrifugation procedure.
    Layer RT
    Curr Protoc Neurosci; 2001 May; Chapter 7():Unit7.7. PubMed ID: 18428533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyzing radioligand binding data.
    Motulsky H; Neubig R
    Curr Protoc Neurosci; 2002 Aug; Chapter 7():Unit 7.5. PubMed ID: 18428565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand binding assays at equilibrium: validation and interpretation.
    Hulme EC; Trevethick MA
    Br J Pharmacol; 2010 Nov; 161(6):1219-37. PubMed ID: 20132208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saturation assays of radioligand binding to receptors and their allosteric modulatory sites.
    Basile A
    Curr Protoc Neurosci; 2001 May; Chapter 7():Unit7.6. PubMed ID: 18428532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of allosteric interactions at G protein-coupled receptors using radioligand binding assays.
    Leach K; Sexton PM; Christopoulos A
    Curr Protoc Pharmacol; 2011 Mar; Chapter 1():Unit 1.22. PubMed ID: 21935902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of scintillation proximity assay to measure radioligand binding to immobilized receptors without separation of bound from free ligand.
    Berry J; Price-Jones M; Killian B
    Methods Mol Biol; 2012; 897():79-94. PubMed ID: 22674161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand dissociation constants from competition binding assays: errors associated with ligand depletion.
    Goldstein A; Barrett RW
    Mol Pharmacol; 1987 Jun; 31(6):603-9. PubMed ID: 3600604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor binding techniques.
    Frey KA; Albin RL
    Curr Protoc Neurosci; 2001 May; Chapter 1():Unit1.4. PubMed ID: 18428450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microplate gel-filtration method for radioligand-binding assays.
    Liu J; Zacco A; Piser TM; Scott CW
    Anal Biochem; 2002 Sep; 308(1):127-33. PubMed ID: 12234473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring receptor target coverage: a radioligand competition binding protocol for assessing the association and dissociation rates of unlabeled compounds.
    Sykes DA; Dowling MR; Charlton SJ
    Curr Protoc Pharmacol; 2010 Sep; Chapter 9():Unit 9.14. PubMed ID: 22294377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive protein-binding analysis of vitamin B12 using Lactobacillus leichmannii as a specific binder.
    van de Wiel DF; de Vries JA; Woldring MG; Nieweg HO
    Clin Chim Acta; 1974 Sep; 55(2):155-63. PubMed ID: 4458985
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity.
    Reith ME; Wang LC; Dutta AK
    J Neurosci Methods; 2005 Apr; 143(1):87-94. PubMed ID: 15763140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.
    Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC
    Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radioreceptor analysis: the theoretical bases of the method].
    Zaĭtsev SV; Sergeeva MG; Varfolomeev SD
    Bioorg Khim; 1985 Mar; 11(3):370-9. PubMed ID: 4004954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing radioligand binding data.
    Motulsky H; Neubig R
    Curr Protoc Protein Sci; 2001 May; Appendix 3():Appendix 3H. PubMed ID: 18429075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of CGRP receptor binding.
    Conner AC; Hay DL; Poyner DR
    Curr Protoc Pharmacol; 2004 Sep; Chapter 1():Unit 1.30. PubMed ID: 22294116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.
    Ehlert FJ
    Mol Pharmacol; 1988 Feb; 33(2):187-94. PubMed ID: 2828914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro muscarinic receptor radioligand-binding assays.
    Steinfeld T; Pulido-Rios MT; Armstrong S; Hegde SS
    Curr Protoc Pharmacol; 2010 Mar; Chapter 1():Unit 1.33. PubMed ID: 22294363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Centrifugation or filtration in quantitative radioreceptor assays.
    Ensing K; Feitsma KG; Bloemhof D; In 't Hout WG; de Zeeuw RA
    J Biochem Biophys Methods; 1986 Sep; 13(2):85-96. PubMed ID: 3772026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.